Skip to content

Pericyte Seeded Dual Peptide Scaffold with Improved Endothelialization for Vascular Graft Tissue Engineering

Research output: Contribution to journalArticle

  • Paola Campagnolo
  • Adam J. Gormley
  • Lesley W. Chow
  • Anne Géraldine Guex
  • Paresh A. Parmar
  • Jennifer L. Puetzer
  • Joseph A.M. Steele
  • Alexandre Breant
  • Paolo Madeddu
  • Molly M. Stevens
Original languageEnglish
Pages (from-to)3046-3055
Number of pages10
JournalAdvanced Healthcare Materials
Issue number23
DateAccepted/In press - 27 Sep 2016
DatePublished (current) - 7 Dec 2016


The development of synthetic vascular grafts for coronary artery bypass is challenged by insufficient endothelialization, which increases the risk of thrombosis, and the lack of native cellular constituents, which favors pathological remodeling. Here, a bifunctional electrospun poly(ε-caprolactone) (PCL) scaffold with potential for synthetic vascular graft applications is presented. This scaffold incorporates two tethered peptides: the osteopontin-derived peptide (Adh) on the “luminal” side and a heparin-binding peptide (Hep) on the “abluminal” side. Additionally, the “abluminal” side of the scaffold is seeded with saphenous vein-derived pericytes (SVPs) as a source of proangiogenic growth factors. The Adh peptide significantly increases endothelial cell adhesion, while the Hep peptide promotes accumulation of vascular endothelial growth factor secreted by SVPs. SVPs increase endothelial migration both in a transwell assay and a modified scratch assay performed on the PCL scaffold. Seeding of SVPs on the “abluminal”/Hep side of the scaffold further increases endothelial cell density, indicating a combinatory effect of the peptides and pericytes. Finally, SVP-seeded scaffolds are preserved by freezing in a xeno-free medium, maintaining good cell viability and function. In conclusion, this engineered scaffold combines patient-derived pericytes and spatially organized functionalities, which synergistically increase endothelial cell density and growth factor retention.

    Research areas

  • biofunctionalization, electrospinning, endothelialization, pericytes, tissue engineered vascular graft

Download statistics

No data available



  • Full-text PDF (accepted author manuscript)

    Rights statement: This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Wiley at Please refer to any applicable terms of use of the publisher.

    Accepted author manuscript, 997 KB, PDF document



View research connections

Related faculties, schools or groups